MedPath

Illumina

🇺🇸United States
Ownership
-
Employees
10.6K
Market Cap
-
Website

Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test

Completed
Conditions
Post-natal Cytogenetics
First Posted Date
2011-08-31
Last Posted Date
2016-04-28
Lead Sponsor
Illumina, Inc.
Target Recruit Count
900
Registration Number
NCT01426308
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

🇺🇸

ARUP Laboratories, Salt Lake City, Utah, United States

🇺🇸

Baylor College of Medicine, Houston, Texas, United States

Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA

Completed
Conditions
Detection and Genotyping of Factor V and Factor II Point Mutations
First Posted Date
2009-08-14
Last Posted Date
2011-06-09
Lead Sponsor
Illumina, Inc.
Target Recruit Count
275
Registration Number
NCT00959504
© Copyright 2025. All Rights Reserved by MedPath